Compared to healthy volunteers, pDCs derived from melanoma patients did, however, show a higher expression of CCR6, and increased ability to migrate toward Chemokine (C-C motif) ligand 20 (CCL20), a ligand for CCR6 (144). Here, CCL20 is linked to melanoma.